Medications

US says Teva antidepressant is ineffective

(AP)—Teva Pharmaceuticals has stopped shipping its generic version of a popular antidepressant off the market after a U.S. government analysis showed the pill does not work properly.

Medications

Fearing abuse, US blocks generic OxyContin (Update)

U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.

Medications

Two generic versions of ADHD drug not as effective: FDA

(HealthDay)—Two generic versions of the attention-deficit/hyperactivity disorder drug Concerta may not work as effectively as the brand-name product does, the U.S. Food and Drug Administration said Thursday.

Medications

FDA warns pregnant women about migraine drugs

(HealthDay)—Pregnant women who struggle with migraine headaches should never use medicines containing the ingredient valproate because they can lower the IQ scores of their children, the U.S. Food and Drug Administration ...

Medications

J&J loses key tuberculosis drug patent in India

India's Patent Office rejected on Thursday US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.

Medications

Retailers sue Pfizer, charge generic Lipitor delay

(AP) — Five large U.S. drug and grocery chains are suing Pfizer Inc. and a second drugmaker, alleging they conspired to delay sales of cheap generic versions of the blockbuster cholesterol drug Lipitor.

Medications

FDA approves generic version of celebrex

(HealthDay)—The U.S. Food and Drug Administration on Friday gave its approval to the first generic version of the pain reliever Celebrex (celecoxib).

Medications

FDA: Ziprasidone can cause rare, serious adverse drug reaction

(HealthDay)—The antipsychotic medicine ziprasidone (Geodon) and generic versions of the drug can cause a rare, serious skin reaction that can progress to affect other parts of the body, the U.S. Food and Drug Administration ...

Medications

Bristol-Myers, Sanofi revamp Plavix sales alliance (Update)

(AP)—Bristol-Myers Squibb Co. and France's Sanofi SA said Wednesday that they are restructuring their longtime partnership selling popular heart medications, now that their sales are plunging due to widespread competition ...

page 5 from 10